Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2025-12-25 @ 4:36 PM
Study NCT ID:
NCT01663857
Status:
COMPLETED
Last Update Posted:
2019-09-11
First Post:
2012-08-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study LY2228820 for Recurrent Ovarian Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2017-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-08
First Submit QC Date:
None
Study First Post Date:
2012-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-08
Results First Submit QC Date:
None
Results First Post Date:
2019-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-05-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-08-28
Last Update Post Date:
2019-09-11
Last Update Post Date Type:
ACTUAL